Search research articles
Contact Us
Filters
Showing results (141-150 of 157) with videos related to
Page
of 16
Sort By:
Scientific Reports
|
February 14, 2015
S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase
Pulin Che, Youfeng Yang, Xiaosi Han, et al.
The Journal of Biological Chemistry
|
January 18, 2005
The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3
Merideth C Kamradt, Meiling Lu, Michael E Werner, et al.
Oncotarget
|
November 27, 2016
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Cancers
|
June 12, 2026
Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance
Sindhu Ramesh, Junwei Wang, Chung-Hui Huang, et al.
Oncotarget
|
May 4, 2018
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Cancer Letters
|
May 4, 2024
BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine
Aubrey L Miller, Samuel C Fehling, Rebecca B Vance, et al.
Molecular Oncology
|
June 11, 2016
RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4
Marie K Kirby, Ryne C Ramaker, Jason Gertz, et al.
Cancer Research
|
May 25, 2016
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype
Matthew J Schultz, Andrew T Holdbrooks, Asmi Chakraborty, et al.
Molecular Cancer Therapeutics
|
July 26, 2013
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers
Erik A Bey, Kathryn E Reinicke, Melissa C Srougi, et al.
Therapeutic Advances in Medical Oncology
|
April 22, 2020
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
David W Doo, Selene Meza-Perez, Angelina I Londoño, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 157) with videos related to
Sort By:
Page
of 16
Scientific Reports
|
February 14, 2015
S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase
Pulin Che, Youfeng Yang, Xiaosi Han, et al.
The Journal of Biological Chemistry
|
January 18, 2005
The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3
Merideth C Kamradt, Meiling Lu, Michael E Werner, et al.
Oncotarget
|
November 27, 2016
Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Cancers
|
June 12, 2026
Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance
Sindhu Ramesh, Junwei Wang, Chung-Hui Huang, et al.
Oncotarget
|
May 4, 2018
Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
Rebecca C Arend, Angelina I Londoño-Joshi, Abhishek Gangrade, et al.
Cancer Letters
|
May 4, 2024
BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine
Aubrey L Miller, Samuel C Fehling, Rebecca B Vance, et al.
Molecular Oncology
|
June 11, 2016
RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4
Marie K Kirby, Ryne C Ramaker, Jason Gertz, et al.
Cancer Research
|
May 25, 2016
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype
Matthew J Schultz, Andrew T Holdbrooks, Asmi Chakraborty, et al.
Molecular Cancer Therapeutics
|
July 26, 2013
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers
Erik A Bey, Kathryn E Reinicke, Melissa C Srougi, et al.
Therapeutic Advances in Medical Oncology
|
April 22, 2020
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
David W Doo, Selene Meza-Perez, Angelina I Londoño, et al.
Page
of 16